tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Acne Vulgaris D000152 35 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Akinetic Mutism D000405 1 associated lipids
Albuminuria D000419 18 associated lipids
Alopecia D000505 14 associated lipids
Alopecia Areata D000506 6 associated lipids
Alzheimer Disease D000544 76 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Huang K et al. Novel role for NFAT3 in ERK-mediated regulation of CXCR4. 2014 PLoS ONE pmid:25514788
Singh K et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. 2014 Am. J. Transplant. pmid:25359003
Siebelt M et al. FK506 protects against articular cartilage collagenous extra-cellular matrix degradation. 2014 Osteoarthr. Cartil. pmid:24561282
Tang Q Pharmacokinetics of therapeutic Tregs. 2014 Am. J. Transplant. pmid:25358900
Hamzah S et al. Pharmacogenotyping of CYP3A5 in predicting dose-adjusted trough levels of tacrolimus among Malaysian kidney-transplant patients. 2014 Can. J. Physiol. Pharmacol. pmid:24383873
Amorim J et al. Tacrolimus-induced neutropenia in a cardiac transplant patient. 2014 Pediatr Transplant pmid:24384051
Silva HT et al. Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. 2014 Transplantation pmid:24521771
Kiiski V et al. Long-term safety of topical pimecrolimus and topical tacrolimus in atopic blepharoconjunctivitis. 2014 JAMA Dermatol pmid:24500107
Naganuma M et al. [Clinical relevance of tacrolimus trough levels in outpatients with active ulcerative colitis]. 2014 Nihon Shokakibyo Gakkai Zasshi pmid:24500317
Sahin S et al. The protective effects of tacrolimus on rat uteri exposed to ischemia-reperfusion injury: a biochemical and histopathologic evaluation. 2014 Fertil. Steril. pmid:24502894
Pereira MJ et al. Cyclosporine A and tacrolimus reduce the amount of GLUT4 at the cell surface in human adipocytes: increased endocytosis as a potential mechanism for the diabetogenic effects of immunosuppressive agents. 2014 J. Clin. Endocrinol. Metab. pmid:25004245
Lapeyraque AL et al. Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study. 2014 Pediatr. Nephrol. pmid:24435759
Højfeldt JW et al. Bifunctional ligands allow deliberate extrinsic reprogramming of the glucocorticoid receptor. 2014 Mol. Endocrinol. pmid:24422633
Saso S et al. Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study. 2014 Eur. J. Obstet. Gynecol. Reprod. Biol. pmid:25306223
Mekaj AY et al. Application of topical pharmacological agents at the site of peripheral nerve injury and methods used for evaluating the success of the regenerative process. 2014 J Orthop Surg Res pmid:25303779
Satoh S et al. Pharmacokinetic and CYP3A5 pharmacogenetic differences between once- and twice-daily tacrolimus from the first dosing day to 1 year after renal transplantation. 2014 Pharmacogenomics pmid:25303300
Meyer KC et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. 2014 Eur. Respir. J. pmid:25359357
Ahmed S et al. Photocleavable dimerizer for the rapid reversal of molecular trap antagonists. 2014 J. Biol. Chem. pmid:24421317
Souto-Rodríguez R et al. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol. 2014 Transplant. Proc. pmid:25420839
Al-Amri AM Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. 2014 Am. J. Ophthalmol. pmid:24439439
de la Fuente S et al. Long-term survivors after pediatric liver transplatation are at increased risk for development of cardiovascular disease events: analysis of 30 cases. 2014 Transplant. Proc. pmid:25420837
Kim JR et al. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol-fortified ginseng extract attenuates the development of atopic dermatitis-like symptoms in NC/Nga mice. 2014 J Ethnopharmacol pmid:24269244
Tavira B et al. Mitochondrial DNA haplogroups and risk of new-onset diabetes among tacrolimus-treated renal transplanted patients. 2014 Gene pmid:24445060
Lin Y et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. 2014 Am. J. Pathol. pmid:24269558
Barreiro C and Martínez-Castro M Trends in the biosynthesis and production of the immunosuppressant tacrolimus (FK506). 2014 Appl. Microbiol. Biotechnol. pmid:24272367
Iwanami M et al. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis]. 2014 Rinsho Shinkeigaku pmid:24429649
Masson P et al. Belatacept for kidney transplant recipients. 2014 Cochrane Database Syst Rev pmid:25416857
Xu W et al. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time. 2014 Int J Pharm pmid:24172796
Salehi-Najafabadi Z et al. The gamma-butyrolactone receptors BulR1 and BulR2 of Streptomyces tsukubaensis: tacrolimus (FK506) and butyrolactone synthetases production control. 2014 Appl. Microbiol. Biotechnol. pmid:24562179
Xue W et al. Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. 2014 Chin. Med. J. pmid:24931259
Gomez-Moyano E et al. Periorbital granuloma annulare successfully treated with tacrolimus 0.1% ointment. 2014 Int. J. Dermatol. pmid:23432464
Lalić J et al. Immunosuppressive medication adherence in kidney transplant patients. 2014 Med Princ Pract pmid:24923773
Gijsen VM et al. P450 oxidoreductase *28 (POR*28) and tacrolimus disposition in pediatric kidney transplant recipients--a pilot study. 2014 Ther Drug Monit pmid:24089076
Koren G and Rieder M Measuring oral bioavailability of tacrolimus. 2014 Pediatr Transplant pmid:25250966
Schlegel A et al. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. 2014 Ann. Surg. pmid:25243553
Chen Z et al. Mutations adjacent to the end of transmembrane helices 6 and 7 independently affect drug efflux capacity of yeast ABC transporter Pdr5p. 2014 Biochim. Biophys. Acta pmid:24333836
Ueda K et al. Early corticosteroid withdrawal in the real world: a long-term analysis of kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Registry. 2014 Ann. Transplant. pmid:24535029
Nasu R et al. Favorable outcomes of tacrolimus compared with cyclosporine A for GVHD prophylaxis in HSCT for standard-risk hematological diseases. 2014 Ann. Hematol. pmid:24590535
Kujawski S et al. Calcineurin regulates coordinated outgrowth of zebrafish regenerating fins. 2014 Dev. Cell pmid:24561038
Rahman Z et al. Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized X-ray powder diffraction method with chemometrics. 2014 Int J Pharm pmid:25173870
Jia JJ et al. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. 2014 World J. Gastroenterol. pmid:25170223
Hao JC et al. Effect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation. 2014 World J. Gastroenterol. pmid:25170222
Peng L et al. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. 2014 PLoS ONE pmid:25165975
Vattemi G et al. Polymyositis in solid organ transplant recipients receiving tacrolimus. 2014 J. Neurol. Sci. pmid:25130930
Görzer I et al. Plasma DNA levels of Torque teno virus and immunosuppression after lung transplantation. 2014 J. Heart Lung Transplant. pmid:24559947
Barnieh L et al. The cost of kidney transplant over time. 2014 Prog Transplant pmid:25193726
Calo S et al. Antifungal drug resistance evoked via RNAi-dependent epimutations. 2014 Nature pmid:25079329
Chen SR et al. Calcineurin inhibitor induces pain hypersensitivity by potentiating pre- and postsynaptic NMDA receptor activity in spinal cords. 2014 J. Physiol. (Lond.) pmid:24081160
Guy S et al. Successful treatment of acute severe graft-versus-host-disease in a pancreas-after-kidney transplant recipient: case report. 2014 Transplant. Proc. pmid:25179161
Yuan C et al. A simple and robust LC-MS/MS method for measuring sirolimus and everolimus in whole blood. 2014 Bioanalysis pmid:25077621
Aulagnon F et al. Diarrhea after kidney transplantation: a new look at a frequent symptom. 2014 Transplantation pmid:25073040
Han JS et al. Tacrolimus 0.1% ointment in the treatment of allergic contact dermatitis: a new approach. 2014 Int. J. Dermatol. pmid:25070257
Beermann KJ et al. Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 2014 Clin Transplant pmid:24754564
Matia I et al. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats. 2014 Ann. Transplant. pmid:24815872
Harada N et al. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment]. 2014 Nippon Ganka Gakkai Zasshi pmid:24864437
Denfield SW Oxidative and other stresses following pediatric heart transplantation. 2014 Pediatr Transplant pmid:25250969
Izumi Y et al. Safety of tacrolimus treatment during pregnancy and lactation in systemic lupus erythematosus: a report of two patients. 2014 Tohoku J. Exp. Med. pmid:25175032
Piao SG et al. Combined treatment of tacrolimus and everolimus increases oxidative stress by pharmacological interactions. 2014 Transplantation pmid:24825522
Gujadhur A et al. CMV sinusitis in a HIV-negative renal transplant recipient. 2014 Transplantation pmid:24827770
Anderson JS et al. Statistical allosteric coupling to the active site indole ring flip equilibria in the FK506-binding domain. 2014 Biophys. Chem. pmid:25016286
Navas-López VM et al. Oral tacrolimus for pediatric steroid-resistant ulcerative colitis. 2014 J Crohns Colitis pmid:23582736
van Gelder T et al. Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. 2014 Nat Rev Nephrol pmid:25247332
Tapirdamaz Ö et al. Genetic variance in ABCB1 and CYP3A5 does not contribute toward the development of chronic kidney disease after liver transplantation. 2014 Pharmacogenet. Genomics pmid:25014506
Helmschrott M et al. Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen. 2014 Drug Des Devel Ther pmid:25246772
Matta C et al. Ser/Thr-phosphoprotein phosphatases in chondrogenesis: neglected components of a two-player game. 2014 Cell. Signal. pmid:25007994
Matsuda Y et al. Once-daily oral administration of cyclosporine in a lung transplant patient with a history of renal toxicity of calcineurin inhibitors. 2014 Interact Cardiovasc Thorac Surg pmid:24659549
Hara H et al. Hematopoietic chimerism following allotransplantation of the spleen, splenocytes or kidney in pigs. 2014 Transpl. Immunol. pmid:25245436
Lunde I et al. The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients. 2014 Eur. J. Clin. Pharmacol. pmid:24658827
Picchianti-Diamanti A et al. P-glycoprotein and drug resistance in systemic autoimmune diseases. 2014 Int J Mol Sci pmid:24658440
Andrade-Sierra J et al. Early steroid withdrawal in a renal transplant cohort treated with tacrolimus, mycophenolate mofetil and basiliximab. 2014 Nefrologia pmid:24658197
Webster P et al. Tacrolimus is an effective treatment for lupus nephritis in pregnancy. 2014 Lupus pmid:24928830
Wolfram D et al. Insights from computational modeling in inflammation and acute rejection in limb transplantation. 2014 PLoS ONE pmid:24926998
Zhao X et al. [A retrospective cohort study regarding the effect of sirolimus-based immunosuppression protocol on the long-term survival of hepatocellular carcinoma patients after liver transplantation]. 2014 Zhonghua Wai Ke Za Zhi pmid:24924566
Saito E et al. Efficacy of salvage therapy and its effect on operative outcomes in patients with ulcerative colitis. 2014 Digestion pmid:24458114
Song L et al. Effects of ASKP1240 combined with tacrolimus or mycophenolate mofetil on renal allograft survival in Cynomolgus monkeys. 2014 Transplantation pmid:24992357
Carbajo-Lozoya J et al. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. 2014 Virus Res. pmid:24566223
Ren Y et al. Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. 2014 Int. Immunopharmacol. pmid:24836681
Li H et al. A promising approach of overcoming the intrinsic resistance of Candida krusei to fluconazole (FLC)--combining tacrolimus with FLC. 2014 FEMS Yeast Res. pmid:24830342
Wang YB et al. In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization. 2014 AAPS PharmSciTech pmid:24824172
Oda K et al. In vitro experimental system for evaluating inhibitory effect of investigational drugs on P-glycoprotein-mediated transcellular transport of tacrolimus (FK506). 2014 Biopharm Drug Dispos pmid:24822242
Wang Z et al. Influence of TLR4 rs1927907 locus polymorphisms on tacrolimus pharmacokinetics in the early stage after liver transplantation. 2014 Eur. J. Clin. Pharmacol. pmid:24820765
Akchurin OM et al. Medication adherence in the transition of adolescent kidney transplant recipients to the adult care. 2014 Pediatr Transplant pmid:24820521
Welzl K et al. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons. 2014 Gerontology pmid:24434865
Yang LM et al. Experimental research on end-to-side anastomosis of peripheral nerves and effect of FK506 on end-to-side anastomosis. 2014 Bratisl Lek Listy pmid:25573729
Taimur S et al. Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant. 2014 Transpl Infect Dis pmid:24251680
Stewart JI et al. Reverse halo sign on chest imaging in a renal transplant recipient. 2014 Transpl Infect Dis pmid:24289813
Colom H et al. Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients. 2014 Kidney Int. pmid:24402086
Shihab FS et al. Tacrolimus exposure in the real world: an analysis from the Mycophenolic acid Observational REnal transplant study. 2014 Clin Transplant pmid:24754603
Taube D et al. Generic tacrolimus in solid organ transplantation. 2014 Clin Transplant pmid:24750309
Nacif LS et al. An analysis of tacrolimus-related complications in the first 30 days after liver transplantation. 2014 Clinics (Sao Paulo) pmid:25518032
Varghese J et al. Tacrolimus-related adverse effects in liver transplant recipients: its association with trough concentrations. 2014 Indian J Gastroenterol pmid:24740447
Kawaguch K et al. Successful treatment with allogenic hematopoietic stem cell transplantation of a severe congenital neutropenia patient harboring a novel ELANE mutation. 2014 Rinsho Ketsueki pmid:25501410
Cvetkovic TP et al. Gender differences in oxidative and nitrosative stress parameters in kidney transplant patients on tacrolimus-based immunosuppression. 2014 Int Urol Nephrol pmid:24101297
Nishimoto K et al. [Case of organizing pneumonia associated with sweet's syndrome]. 2014 Arerugi pmid:25163580
Hässig A et al. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor. 2014 Transpl Infect Dis pmid:24134704
Elens L et al. Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocks. 2014 Br J Clin Pharmacol pmid:24118098
Manousou P et al. Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. 2014 Gut pmid:24131637
Langers P et al. Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation. 2014 Ther Drug Monit pmid:24081208
da Cunha Filho RR et al. "Angular" plasma cell cheilitis. 2014 Dermatol. Online J. pmid:24656273
Nakamura A et al. Effects of elevated tacrolimus trough levels in association with infectious enteritis on graft function in renal transplant recipients. 2014 Transplant. Proc. pmid:24656020